Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thorpe

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
The Cochrane Database of Systematic Reviews|March 2, 2020
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseAsmaa S Abdelhamid, Tracey J Brown, Julii S Brainard, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2015
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to FidaxomicinD R Snydman, L A McDermott, N V Jacobus, et al.
The Cochrane Database of Systematic Reviews|July 19, 2018
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseAsmaa S Abdelhamid, Tracey J Brown, Julii S Brainard, et al.
The Cochrane Database of Systematic Reviews|December 7, 2018
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseAsmaa S Abdelhamid, Tracey J Brown, Julii S Brainard, et al.
Journal of Virology|September 29, 2005
Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral responseChi L Ong, Janine C Thorpe, Paul R Gorry, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2014
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosisJ S Bajaj, D M Heuman, P B Hylemon, et al.
BJU International|September 27, 2020
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinomaDavid D'Andrea, Surena Matin, Peter C Black, et al.
BJU International|November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosisFrancesco Soria, Peter C Black, Adrian S Fairey, et al.
The Journal of Urology|August 27, 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder CancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
European Urology Focus|February 19, 2022
Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54]Maria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
The Cochrane Database of Systematic Reviews|March 2, 2020
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseAsmaa S Abdelhamid, Tracey J Brown, Julii S Brainard, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2015
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to FidaxomicinD R Snydman, L A McDermott, N V Jacobus, et al.
The Cochrane Database of Systematic Reviews|July 19, 2018
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseAsmaa S Abdelhamid, Tracey J Brown, Julii S Brainard, et al.
The Cochrane Database of Systematic Reviews|December 7, 2018
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseAsmaa S Abdelhamid, Tracey J Brown, Julii S Brainard, et al.
Journal of Virology|September 29, 2005
Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral responseChi L Ong, Janine C Thorpe, Paul R Gorry, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2014
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosisJ S Bajaj, D M Heuman, P B Hylemon, et al.
BJU International|September 27, 2020
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinomaDavid D'Andrea, Surena Matin, Peter C Black, et al.
BJU International|November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosisFrancesco Soria, Peter C Black, Adrian S Fairey, et al.
The Journal of Urology|August 27, 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder CancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
European Urology Focus|February 19, 2022
Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54]Maria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
Pageof 23